Expertise in
8
conditions

Marzena H. Olesinska

Warsaw, MZ, PL 
Expertise in
8
conditions
Warsaw, MZ, PL 

Overview

Marzena Olesinska practices practicing medicine in Warsaw, Poland.

Ms. Olesinska is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Mixed Connective Tissue Disease, Systemic Lupus Erythematosus (SLE), Scleroderma, Systemic Sclerosis (SSc), and Synovectomy.

She is actively involved in clinical research, co-authoring 112 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Warsaw, MZ, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Enrollment Status: Completed
Publish Date: August 16, 2022
Intervention Type: Drug
Study Drug: Lenabasum
Study Phase: Phase 3
View 1 Less Clinical Trial

112 Total Publications

Suspected shrinking lung syndrome: a rare pulmonary manifestation of systemic lupus erythematosus-a case-based review of an underrecognized condition.
Suspected shrinking lung syndrome: a rare pulmonary manifestation of systemic lupus erythematosus-a case-based review of an underrecognized condition.
Journal: Rheumatology international
Published: July 31, 2026

Frequently Asked Questions about Marzena H. Olesinska

Is Marzena H. Olesinska a top-rated expert for Mixed Connective Tissue Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Marzena H. Olesinska is classified as an Elite expert for Mixed Connective Tissue Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Marzena H. Olesinska participate in research or clinical trials?

Yes. Marzena H. Olesinska has published 112 articles and abstracts on conditions like Mixed Connective Tissue Disease. You can view a list of Marzena H. Olesinska's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Olesinska's expertise for a condition
ConditionClose
View All 22 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile